Related by context. All words. (Click for frequent words.) 70 Cethromycin 69 Restanza 67 ceftaroline 65 fidaxomicin 63 elotuzumab 63 doripenem 63 posaconazole 62 Traficet EN 62 TYGACIL 62 PRT# 62 BAL# [002] 61 NXL# 61 Anthim 61 OHR/AVR# 61 torezolid phosphate 61 anidulafungin 61 oral prodrug 61 vidofludimus 61 daptomycin 61 reslizumab 61 forodesine 61 ONCONASE 60 delafloxacin 60 alvimopan 60 Phenoptin 60 HuMax CD4 60 iclaprim 60 radezolid 60 oral FTY# 60 Bicifadine 60 nitazoxanide 60 HuMax CD# 60 Noxafil 60 ozarelix 60 aclidinium 60 tigecycline 60 Telavancin 60 Locteron 60 Ramoplanin 60 Anidulafungin 60 methylnaltrexone 59 otelixizumab 59 Altastaph 59 oritavancin 59 tipranavir 59 GFT# 59 talactoferrin 59 rilonacept 59 Numax 59 valopicitabine 59 antiviral efficacy 59 ceftazidime 59 lomitapide 59 torezolid 59 edoxaban 59 JAK inhibitor 59 Nexavar ® 59 lucinactant 59 Radezolid 59 oral methylnaltrexone 59 Dalbavancin 59 amrubicin 59 CoFactor 59 tolvaptan 59 Onconase 59 ATL# [001] 59 INCB# [002] 59 mapatumumab 59 elvucitabine 59 AZILECT ® 59 FluINsure 59 HspE7 59 balsalazide tablet 59 riociguat 59 teduglutide 59 Onbrez Breezhaler 58 Aclidinium 58 tecarfarin 58 Tygacil 58 isavuconazole 58 Serdaxin 58 celgosivir 58 bardoxolone 58 Phase 2b study 58 ketolide antibiotic 58 oral antiviral 58 tanespimycin 58 Tavocept 58 Valortim 58 refractory gout 58 daclizumab 58 Catena ® 58 Thiovir 58 velafermin 58 canakinumab 58 DXL# 58 eniluracil 58 ARCOXIA 58 vernakalant 58 dalbavancin 58 atacicept 58 AEGR 58 teriflunomide 58 plus ribavirin 58 motavizumab 58 dacetuzumab 58 Virulizin ® 58 ULORIC 58 Corlux 58 favorable pharmacokinetic profile 58 Infergen 58 ACTEMRA TM 58 Mycamine 58 phase IIb 58 PROMACTA 58 maribavir 58 ELACYT 58 S/GSK# 58 AEG# 58 Darusentan 58 Chemophase 58 LymphoStat B 58 pradefovir 58 Tarvacin TM 58 CYT# 58 lumiliximab 58 macrolide 58 CIMZIA ™ 58 PRTX 58 BARACLUDE ® 58 Amplimexon 58 NOXAFIL 58 Pruvel 58 CCX# 58 Targretin 57 LibiGel ® 57 Viramidine 57 phase IIa clinical 57 Protexia R 57 Plicera 57 micafungin 57 Dificid 57 sorafenib tablets 57 CIMZIA TM 57 REMICADE ® 57 Pennsaid R 57 Neurodex 57 Azedra 57 neuraminidase inhibitor 57 T Pred 57 Civacir 57 bevirimat 57 Tarvacin 57 Valortim ® 57 Archexin 57 MAXY G# 57 cannabinor 57 varespladib 57 Phase 1b 57 linaclotide 57 Phase Ib study 57 AzaSite Plus 57 Hyphanox 57 Aflibercept 57 AZILECT R 57 ONTAK 57 PEG Interferon lambda 57 TYZEKA 57 elagolix 57 Fodosine 57 tolerability profile 57 voclosporin 57 PXD# 57 Pimavanserin 57 Vfend 57 IRESSA 57 Azilect ® 57 GAMMAGARD 57 ZADAXIN 57 ganetespib 57 UPLYSO 57 CR# vcMMAE 57 Doribax 57 Zemplar Capsules 57 phase IIa 57 brivaracetam 57 rhThrombin 57 TMC# [001] 57 GLPG# 57 Phase 2a trial 57 RSD# oral 57 retapamulin 57 CANCIDAS 57 PREOS 57 pharmacokinetic PK study 57 YONDELIS 57 IFN Beta 57 NVA# 57 Ambrisentan 57 telbivudine 57 Q#IR 57 Tarceva TM 57 ARIKACE 57 OncoVEX GM CSF 57 HuLuc# 57 silodosin 57 Phase Ib 57 EndoTAG TM -1 57 APTIVUS r 57 R#/MEM # 57 MAP# 57 ranolazine 57 RAPAFLO 57 Valortim R 57 pomalidomide 57 Bronchitol 57 Icatibant 57 Northera 57 ZYBRESTAT 57 phase Ib 57 solithromycin 57 vilazodone 56 prucalopride 56 Tamibarotene 56 XmAb# 56 Amigal 56 picoplatin 56 Phase Ib clinical 56 betrixaban 56 custirsen 56 SCH # 56 APTIVUS 56 BARACLUDE R 56 ORENCIA ® 56 viral kinetics 56 PEG SN# 56 denufosol 56 EOquin 56 Firazyr 56 CRMD# 56 SparVax TM 56 casopitant 56 GALNS 56 FluCide 56 cobiprostone 56 PROSTVAC TM 56 MYCAMINE 56 Alocrest 56 PCK# 56 Phase 1b trial 56 ProSavin 56 StaphVAX 56 liprotamase 56 DAVANAT 56 Arcalyst 56 Alpharadin 56 ponatinib 56 tolevamer 56 oral bioavailability 56 LT NS# 56 Fulvestrant 56 TG# [003] 56 Dacogen injection 56 Phase Ib II 56 trabectedin 56 sitaxsentan 56 dirucotide 56 Sym# 56 ularitide 56 nanoviricides 56 SinuNase 56 EOquin TM 56 albinterferon alfa 2b 56 Menerba 56 EVIZON 56 alvespimycin 56 CDP# 56 linezolid 56 invasive aspergillosis 56 tipifarnib 56 Mipomersen 56 zileuton 56 DR Cysteamine 56 PSN# [002] 56 RSD# 56 pharmacodynamic properties 56 oral ridaforolimus 56 HZT 56 VEGF Trap 56 Inhalation Solution 56 Aplidin 56 potent antiviral 56 Prochymal 56 LAF# 56 tocilizumab 56 BAY #-# 56 MAGE A3 ASCI 56 Phase #/#a 56 pegloticase 56 Zelrix 56 NEBIDO 56 Zenvia Phase III 56 Velcade bortezomib 56 OncoVEX 56 Exelixis XL# 56 Tasimelteon 56 obatoclax 56 MGCD# [001] 56 ISENTRESS 56 HCV protease inhibitor 56 ENMD # 56 Synavive 56 YERVOY 56 tivozanib 56 INCB# [001] 56 TBC# 56 Phase IIa clinical 56 bicifadine 56 Cloretazine 56 Dapagliflozin 56 Omigard 56 NEUMUNE 56 efficacy 56 piperacillin tazobactam 56 FOLOTYN ® 56 rNAPc2 56 davunetide intranasal AL 55 pegylated interferon alfa 55 RhuDex ® 55 Pazopanib 55 REP# 55 telaprevir VX 55 PEG interferon 55 ancrod 55 BYDUREON 55 ALTU 55 ocrelizumab 55 Albuferon 55 incyclinide 55 echinocandins 55 oral Xeloda 55 Xinlay 55 Bezielle 55 OvaRex R 55 IDX# 55 retigabine 55 CCR5 antagonist 55 Rezular 55 Panzem 55 MYDICAR 55 Triolex 55 Virulizin R 55 trastuzumab DM1 T DM1 55 eltrombopag 55 MDV# 55 subcutaneously administered 55 Acetavance 55 pharmacodynamic 55 CBLC# 55 ALN RSV# 55 danoprevir 55 iSONEP 55 Alferon N 55 CEQ# 55 phase IIb clinical 55 Kuvan 55 vancomycin 55 dimebon 55 SinuNase TM 55 Azedra TM 55 BCX# 55 PS# [001] 55 HuMax EGFr 55 Amrubicin 55 MoxDuo TM IR 55 Myocet 55 regorafenib 55 Phase IIb trials 55 subcutaneous formulation 55 ATACAND 55 IMA# 55 PROCHYMAL 55 Neuradiab 55 amphotericin B 55 GSK# [001] 55 sunitinib malate 55 PF # [001] 55 BEXXAR 55 Nasulin 55 CINTREDEKIN BESUDOTOX 55 diabetic neuropathic pain 55 MyVax 55 Clevudine 55 ADVANCE PD 55 DORIBAX 55 CD# monoclonal antibody 55 Phase #b/#a 55 tezampanel 55 ambrisentan 55 Perforomist ™ Inhalation Solution 55 Lialda 55 ALKS 55 NP2 Enkephalin 55 ASONEP 55 Aptivus 55 pegylated interferon alpha 55 MBP# [001] 55 Ketotransdel 55 liposomal formulation 55 octreotide acetate 55 QNEXA 55 TNFerade 55 Zerenex 55 TRIOLEX 55 CXB# 55 ISIS # 55 Itopride 55 eculizumab 55 Hsp# inhibitor 55 GAP #B# 55 EGFR antibodies 55 SEBIVO 55 EFAPROXYN 55 Marqibo 55 rFIXFc 55 ruboxistaurin 55 AP# [003] 55 Peramivir 55 Telbivudine 55 STELARA 55 SILENOR 55 oral rivaroxaban 55 PDE4 inhibitor 55 Phase 1a clinical 55 XL# [003] 55 talabostat 55 tesmilifene 55 TOLAMBA 55 Fibrillex TM 55 ara C 55 mRCC 55 caspofungin 55 quinolone 55 entecavir 55 glatiramer acetate 55 mITT population 55 VAPRISOL 55 Ostarine 55 ALN TTR 55 PEGPH# 55 ACZ# 55 Ceflatonin 55 ThermoDox ® 55 Tindamax R 55 CCR9 antagonist 55 inhaled iloprost 55 HQK 55 DDP# 55 alefacept 55 antiviral activity 55 dose cohorts 55 MYDICAR ® 55 Levofloxacin 55 Phase IIIb clinical 55 Golimumab 55 BrachySil TM 55 ENBREL 55 Aurexis 55 atrasentan 55 ELND# 54 Tipranavir 54 bactericidal activity 54 Non inferiority 54 darusentan 54 rifaximin 54 Pirfenidone 54 TNF alpha inhibitor 54 Dextofisopam 54 VIDAZA 54 CTAP# Capsules 54 aflibercept 54 Xanafide 54 Allovectin 7 54 Aptivus ® 54 chemotherapy induced neutropenia 54 carfilzomib 54 Cinryze 54 cystinosis patients 54 C2L 54 Cancidas 54 Satraplatin 54 Octreolin 54 bifeprunox 54 Phase IIb clinical 54 Relovair 54 Hycamtin 54 satraplatin 54 Factive 54 Darinaparsin 54 alpha 2a 54 HBeAg seroconversion 54 Intravail R 54 GLYX 54 Elagolix 54 STELARA ™ 54 secondary efficacy endpoints 54 cilengitide 54 CG# [003] 54 OMAPRO 54 orBec 54 mycophenolate mofetil 54 FOLOTYN 54 Capesaris 54 renin inhibitor 54 favorable tolerability 54 INT# [002] 54 mg dose 54 aprepitant 54 budesonide foam 54 LIALDA 54 ZK EPO 54 ONGLYZA ™ 54 FTY# fingolimod 54 Talabostat 54 dose cohort 54 Maribavir 54 oral gallium 54 Tyrima 54 clevudine 54 ADAGIO study 54 panitumumab 54 BENLYSTA 54 Alinia 54 apremilast 54 icatibant 54 efalizumab 54 ceftobiprole 54 maximally tolerated dose 54 Reverset 54 MabCampath 54 topical antimicrobial 54 DU #b 54 Guanilib 54 CTCE 54 palonosetron 54 evaluating tivozanib 54 MORAb 54 febuxostat 54 NUVIGIL 54 SRT# [003] 54 HUMIRA 54 REMINYL ® 54 fluticasone furoate 54 VELCADE melphalan 54 docetaxel Taxotere ® 54 glufosfamide 54 TKM ApoB 54 Azixa 54 Onrigin 54 CRx 54 PEGylated interferon beta 1a 54 IMGN# 54 SNT MC# 54 HGS ETR1 54 ITMN 54 protease inhibitor PI 54 TroVax 54 Allovectin 7 R 54 ORENCIA R 54 Omacetaxine 54 Actemra tocilizumab 54 recombinant subunit vaccine 54 CD3 monoclonal antibody 54 trodusquemine 54 rindopepimut 54 JAK inhibitors 54 microbiological eradication 54 APRISO 54 Asentar 54 Cimzia TM 54 BENLYSTA ® 54 NEUGENE 54 Nuvion 54 Phase 1b clinical 54 Vilazodone 54 thymalfasin 54 Proxinium TM 54 #D#C# 54 ProLindac 54 rHuPH# 54 gemifloxacin 54 MEK inhibitor 54 Symadex 54 macrolide antibiotic 54 PrevOnco 54 QLT# 54 virus HCV protease inhibitor 54 ONGLYZA 54 Daclizumab 54 Vandetanib 54 relapsed multiple myeloma 54 ulimorelin 54 PEG INTRON 54 imipenem 54 omacetaxine mepesuccinate 54 VA# [002] 54 OMNARIS HFA 54 SPIRIVA HandiHaler 54 omacetaxine 54 MGCD# [002] 54 sulodexide 54 Dasatinib 54 Forodesine HCl 54 Rhucin 54 Fibrin Pad 54 Cetrorelix 54 Phase 2b trial 54 telavancin 54 OPAXIO 54 IPLEX 54 menadione 54 CAELYX 54 bavituximab 54 ZOLINZA 54 baminercept 54 oxymorphone ER 54 apaziquone 54 pharmacokinetics PK 54 BRAF inhibitor 54 Initiate Phase 54 Octreotide 54 ruxolitinib 54 HBeAg positive patients 54 HCD# [002] 54 desvenlafaxine succinate 54 PLK1 SNALP 54 lixisenatide 54 OXi# 54 noninferiority 54 Vidofludimus 54 ChronVac C R 54 indiplon capsules 54 Nitazoxanide 54 GLP toxicology studies 53 vemurafenib 53 Panzem R 53 indibulin 53 trospium 53 Oracea 53 rALLy trial 53 lanthanum carbonate 53 PEG Intron 53 ChimeriVax JE 53 viral kinetic 53 MAXY alpha 53 pharmacokinetic PK 53 TRV# [001] 53 ribavirin RBV 53 NKTR 53 IRX 2 53 Phase 2b clinical 53 HDAC Inhibitor 53 Panzem R NCD 53 phase IIb trial 53 nanoviricide 53 ustekinumab 53 virologic 53 lesinurad 53 KRN# 53 recurrent GBM 53 FTY# 53 phase 2a 53 antiviral potency 53 Atiprimod 53 AmBisome 53 μg dose 53 Telaprevir 53 clevidipine 53 BLA filing 53 Zadaxin 53 RDEA# 53 Cleviprex TM clevidipine 53 efficacy tolerability 53 COPAXONE ® 53 Japanese Encephalitis vaccine 53 INTELENCE 53 BiovaxID 53 mipomersen 53 TRISENOX 53 receptor tyrosine kinase inhibitor 53 preclinical efficacy 53 Rivaroxaban 53 ganciclovir 53 Romidepsin 53 pharmacokinetic studies 53 JANUVIA 53 TriRima 53 Nanobody 53 Pivotal Phase III 53 HCV polymerase inhibitor 53 Sebivo 53 Taxotere ® 53 romidepsin 53 ibandronate 53 intranasal formulation 53 nucleotide analog 53 Factor VIIa 53 cidofovir 53 efficacy endpoint 53 VFEND 53 SUTENT 53 Stedivaze 53 LCP Tacro 53 Viprovex 53 selective orally bioavailable 53 telaprevir 53 BioVant 53 Junovan 53 fluconazole 53 HGS ETR2 53 Ranolazine 53 tolerability profiles 53 abatacept 53 renal toxicity 53 NATRECOR R 53 Phase IIB 53 chlorambucil 53 refractory AML 53 tacrolimus ointment 53 blinatumomab 53 Carfilzomib 53 Rifampin 53 crizotinib PF # 53 CCX# B 53 PD LID 53 NGX# 53 NEVO ™ 53 oral antifungal 53 polymerase inhibitors 53 nucleoside analog 53 pharmacokinetic pharmacodynamic 53 LymphoStat B belimumab 53 pramlintide metreleptin combination 53 mertansine 53 non inferiority 53 RAPAFLO R 53 ximelagatran 53 Gefitinib 53 ROTARIX 53 Phase IIb 53 investigational hepatitis C 53 NDA submission 53 Gleevec imatinib mesylate 53 volociximab 53 ofatumumab 53 zafirlukast 53 Ganciclovir 53 ritonavir boosted 53 therapeutic monoclonal antibodies 53 PEG PAL 53 Phase IIb clinical trials 53 Spiegelmer ® 53 amprenavir 53 Nexavar sorafenib 53 clinical endpoints 53 REYATAZ R 53 heterozygous FH 53 salmeterol fluticasone 53 lubiprostone 53 Famvir 53 blinded randomized placebo controlled 53 anticancer agent 53 phase IIb study 53 AVP #D# 53 INVEGA ® 53 monoclonal antibody MAb 53 Irinotecan 53 Dual Opioid 53 Epratuzumab 53 Trizytek 53 SNRI 53 QAB# 53 ROTATEQ 53 GRN# 53 Pseudomonas aeruginosa infections 53 mTOR inhibitors 53 MOZOBIL 53 axitinib 53 preclinical 53 laninamivir 53 samalizumab 53 peginterferon alfa 2a 53 erlotinib Tarceva ® 53 Xcytrin 53 muraglitazar 53 liposomal amphotericin B 53 Laquinimod 53 Interferon alpha 53 pain palliation 53 RG# [001] 53 palifosfamide 53 Pivotal Phase 53 Hepsera 53 HCV protease inhibitors 53 Ixempra 53 KNS # 53 Phase 2a clinical 53 Antiviral 53 BIBW 53 mg QD 53 metastatic RCC 53 bosutinib 53 Phase 2a 53 endothelin receptor antagonists 53 tolerability 53 successfully commercialize Iluvien 53 RGB # 53 sorafenib 53 enzastaurin 53 FavId 53 tesetaxel 53 Blinatumomab 53 ARIXTRA 53 BrachySil 53 Annamycin 53 oseltamivir Tamiflu ® 53 AAG geldanamycin analog 53 echinocandin 53 MoxDuo IR 53 aflibercept VEGF Trap 53 indacaterol 53 clinical pharmacology studies 53 Actilon 53 ARIKACE ™ 53 Bortezomib 53 BNC# 53 NEUPOGEN 53 oral antibiotic 53 confirmatory clinical 53 QD dosing 53 pertuzumab 53 taribavirin 53 oral diclofenac 53 BRIM2 53 Plenaxis TM 53 Insegia 53 Zalbin 53 humanized anti 53 ongoing Phase 1b 53 Dabigatran etexilate 53 perifosine 53 pegylated interferon alfa 2b 53 pan HDAC inhibitor 53 OvaRex ® MAb 53 Levadex 53 naproxcinod 53 ATL# [002] 53 taxane 53 Dacogen decitabine 53 ACTEMRA 53 ANA# 53 ALGRX 53 MNTX 53 lupus nephritis 53 mg kg dose 53 NATRECOR ® 53 ABC/3TC 53 darapladib 53 galiximab 53 eszopiclone 53 Phase IIa trial 53 MERLIN TIMI 52 milatuzumab 52 ocular formulation 52 abiraterone acetate 52 etanercept Enbrel 52 VEGF Trap Eye 52 Aflunov 52 pegylated interferon alpha 2a 52 virologic response 52 nucleotide analogue 52 TELCYTA 52 BAL# [001] 52 TYSABRI 52 registrational 52 vismodegib 52 MEK inhibitor RDEA# 52 LymphoStat B TM 52 miconazole 52 mcg dose 52 cangrelor 52 recurrent genital herpes 52 PSMA ADC 52 metastatic castration resistant 52 TMC# C# 52 direct thrombin inhibitors 52 Phase III clinical trials 52 granisetron 52 PrevOnco ™ 52 Vectibix 52 L BLP# 52 Aliskiren 52 BRIM3 52 #I TM# 52 Phase III clinical 52 CaPre TM 52 Cubicin 52 Copegus ribavirin 52 placebo controlled clinical trials 52 Increlex R 52 initiate Phase 1b 52 Phase IIa 52 elesclomol 52 sorafenib Nexavar 52 proteasome inhibitor 52 Virulizin 52 HCV polymerase 52 Phase III HEAT 52 TEMODAL 52 Vectibix monotherapy 52 Zalypsis 52 selective androgen receptor modulator 52 fosbretabulin 52 nucleoside 52 GW# [003] 52 efficacy endpoints 52 INCB# [003] 52 mecamylamine 52 voreloxin 52 adalimumab 52 DB# [003] 52 Boceprevir 52 immunomodulator 52 docetaxel Taxotere R 52 pharmacodynamic PD 52 vandetanib 52 integrase inhibitor 52 bazedoxifene 52 cefepime 52 Targretin capsules 52 TREDAPTIVE 52 interferon alfa 52 CD# antibody [001] 52 HIF PH inhibitors 52 ILLUMINATE 52 IAP inhibitors 52 TREANDA 52 Cotara 52 Vidaza azacitidine 52 abatacept Orencia 52 Ophena TM 52 enoximone 52 Jevtana 52 APPRAISE 52 Phase 2b 52 lurasidone 52 huN# DM1 52 histone deacetylase inhibitor 52 Pegasys plus Copegus 52 lapatinib Tykerb 52 peginesatide 52 azoles 52 HEPLISAV 52 Zometa zoledronic acid 52 Hsp# Inhibitor 52 Perifosine 52 APTIVUS R 52 noninfectious uveitis 52 VIRAMUNE XR 52 tezampanel NGX# 52 Pharmacokinetic 52 Intranasal 52 DAS# [001] 52 PREZISTA r 52 ImmunoVEX HSV2 52 Exherin TM 52 TCAD therapy 52 belinostat 52 QVA# 52 Lupuzor 52 Zolinza 52 M6G 52 analgesic efficacy 52 MGd 52 randomized Phase 2b 52 Zenvia 52 HCV RESPOND 2 52 AEZS 52 LCP AtorFen 52 Pegasys peginterferon alfa 2a 52 Vibativ 52 alicaforsen enema 52 SVR# 52 influenza VLP vaccine 52 TransVax ™ 52 metastatic hormone refractory 52 alfa 2a 52 peginterferon 52 MAA submission